Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Ohio › Cleveland
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Cleveland, OH keessatti
Qorannoo 8 Luukemiya Limfoositiikii Keessummaa f Cleveland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Namoota walitti qabaa jiraSadarkaa 3
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Hillcrest Hospital Cancer Center, Mayfield Heights · Miili 12 fagaatti
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Namoota walitti qabaa jiraSadarkaa 3
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Hillcrest Hospital Cancer Center, Mayfield Heights · Miili 12 fagaatti
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
- University Hospitals, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Namoota walitti qabaa jiraSadarkaa 2
- The Cleveland Clinic Foundation, Cleveland
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Cleveland Clinic, Cleveland
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 3
- Cleveland Clinic Main Campus /ID# 271292, Cleveland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University Hospitals Cleveland Medical Center, Cleveland
Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Washington, DCQorannoo 22
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 18
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Chicago, ILQorannoo 14
- Cincinnati, OHQorannoo 14
Qorannoo biroo Cleveland keessatti
- Kansara Qara'a Non-Small CellQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 36
- Saree OljooQorannoo 35
- Kansarii ProstateQorannoo 34
- Cufama OnneeQorannoo 33
- Kansarii OvariiQorannoo 30
- Kansara MetastatikiiQorannoo 30
- Dhibee QaraQorannoo 26
- Kansarii ColorectalQorannoo 24
- Dhibee Onneessaa fi DhiigaQorannoo 22
- Kansa EndometiriyaaliiQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.